Nanjing Pharmaceutical Company Overview
- Founded
- 1951
- Status
- Public
- Employees
- 5,033
- Stock Symbol
- 600713
- Investments
- 2
- Share Price
- $0.71
- (As of Friday Closing)
Nanjing Pharmaceutical Company General Information
Description
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Contact Information
Primary Industry
Distributors/Wholesale (B2C)
Other Industries
Specialty Retail
Medical Supplies
Stock Exchange
SHG
Primary Office
- Number 486 Zhongshan East Road
- Nanjing, 210002
- China
+850 0000000000
Nanjing Pharmaceutical Company Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.71 | $0.70 | $0.58 - $0.77 | $743M | 1.04B | 6.15M | $0.06 |
Nanjing Pharmaceutical Company Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
|---|---|---|---|---|
| EV | 1,483,761 | 1,546,577 | 1,240,147 | 1,063,495 |
| Revenue | 6,205,623 | 5,763,441 | 5,377,377 | 4,731,931 |
| EBITDA | 149,557 | 161,487 | 156,005 | 133,255 |
| Net Income | 59,298 | 54,485 | 50,208 | 39,952 |
| Total Assets | 3,903,229 | 3,583,116 | 3,139,372 | 2,842,683 |
| Total Debt | 1,187,010 | 940,344 | 452,298 | 441,705 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Nanjing Pharmaceutical Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Nanjing Pharmaceutical Company‘s full profile, request access.
Request a free trialNanjing Pharmaceutical Company Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Yu Liang | President & Director | ||
| Wei Li | Chief Financial Officer | ||
| Xiao Jiang | Chief Operating Officer & Secretary | ||
| Jian Tang | Chief Quality Control Officer |
Nanjing Pharmaceutical Company Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000 0000 | Self | Director | 000 0000 |
| 00000 00000 | Self | Director | 000 0000 |
| 000 0000 | Self | Director | 000 0000 |
| 000 0000 | Self | Chairman | 000 0000 |
| 00 00 | Self | Director | 000 0000 |
Nanjing Pharmaceutical Company Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNanjing Pharmaceutical Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Nanjing Pharmaceutical Company‘s full profile, request access.
Request a free trialNanjing Pharmaceutical Company Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000000 0 | 25-Jul-2017 | 000000000 00000000 | Pharmaceuticals | ||
| Fujian Southeast Pharmaceutical | Merger/Acquisition | Pharmaceuticals |